European Attitudes and Outcomes Regarding Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Multinational Survey

Villarroya-Marquina, Inés; Moshrefi, Shawn; Sheckter, Clifford C.; Lee, Gordon K.

doi:10.1007/s00266-020-01736-9

Cited by 2 publications

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Since 2009, a balance between the two types of implants was noticed, and after 2011, surgeons preferred smooth implants over textured implants (18). A multinational survey conducted in Europe and published in 2020 showed that most surgeons (70%) prefer textured implants and that only 29% of those who changed their preferences in terms of the implant surface and manufacturing company did so to prevent the occurrence of BIA-ALCL (28). A Portuguese study by Cunha et al (10) showed that of 57 (27 state and 28 private) hospitals, one hospital mostly used breast implants with a smooth surface, whereas others preferred textured implants (10).…”

Section: New Approaches Of Cosmetic and Reconstructive Breast Surgerymentioning

confidence: 99%

New Data on the Epidemiology of Breast Implant- Associated Anaplastic Large Cell Lymphoma

Ionescu

Vibert²,

Amé

et al. 2021

EJBH

View full text Add to dashboard Cite

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare form of non-Hodgkin's T-cell, CD30-positive, and anaplastic lymphoma kinase-negative lymphoma that develops around breast implants, especially those with a textured surface, used in both cosmetic surgery and reconstructive surgery (1, 2). The first case was reported in 1997 by Keech and Creech (3). In June 2011, the Food and Drug Administration (FDA) identified for the first time a possible association between breast implants and the development of large cell anaplastic lymphoma. In 2016, the World Health Organization admitted BIA-ALCL as a possible long-term complication of breast implants (4), and in 2017, this variant of T-cell lymphoma was included in the classification of lymphoid neoplasms (5).

show abstract

Section: New Approaches Of Cosmetic and Reconstructive Breast Surgerymentioning

confidence: 99%

New Data on the Epidemiology of Breast Implant- Associated Anaplastic Large Cell Lymphoma

Ionescu

Vibert²,

Amé

et al. 2021

EJBH

View full text Add to dashboard Cite

show abstract

“…The available evidence gap continues to persist, due to the lack of data from our region, without knowing manifestations, management, outcomes and prognoses, as well as patient perception and surgeon knowledge. O ther studies, focused on the self-perceived knowledge of plastic surgeons, determined that of 254 surveyed European surgeons, 73% were unaware of this (28) disease, and only 8% had faced a case of these .…”

Section: Surgical Outcomes and Evolution Of Cancer Associated With Br...mentioning

confidence: 99%

Clinical considerations and surgical outcomes of breast implant-associated cancer: An emerging disease of interest

Manjarres Guevara,

Montalvo Clavijo,

Martinez Sierra

et al. 2023

RFMH

View full text Add to dashboard Cite

Breast cancer continues to be one of the main priorities in global health and public health, and remains the most frequent and deadly malignant neoplasm in women worldwide. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare type of non-Hodgkin's lymphoma, whose pathogenesis and pathophysiology are not well known, but which is seen with increasing frequency due to the increase in cosmetic procedures. To date, there are limitations in terms of knowledge about the clinical behavior of the disease, which can manifest itself in many forms, with a variable evolution time and uncertain surgical outcomes in the medium- and long-term. Based on the above, the aim of this review is to summarize evidence on the clinical considerations and surgical outcomes of breast implant-associated cancer to facilitate the identification and management of this condition. A bibliographic search was performed in the search engines and databases PubMed, ScienceDirect, Embase, EBSCO and MEDLINE. Within the clinical and surgical considerations, the type of implant used (textured), the time of the implant history, the severity of the manifestations, and the staging, must be taken into account in order to determine the opportunity for surgical intervention and neoadjuvant therapy, and to try to guarantee survival and avoid recurrence. Patients who undergo complete capsulectomy with radiotherapy have better outcomes.

show abstract

European Attitudes and Outcomes Regarding Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Multinational Survey

Cited by 2 publications

References 18 publications

New Data on the Epidemiology of Breast Implant- Associated Anaplastic Large Cell Lymphoma

New Data on the Epidemiology of Breast Implant- Associated Anaplastic Large Cell Lymphoma

Clinical considerations and surgical outcomes of breast implant-associated cancer: An emerging disease of interest

Contact Info

Product

Resources

About